Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O4KI
|
||||
| Former ID |
DNC008472
|
||||
| Drug Name |
2-ethyl-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529419] | ||
| Formula |
C11H9N3S2
|
||||
| Canonical SMILES |
CCC1=NC2=C(C(=N1)C3=NC=CS3)SC=C2
|
||||
| InChI |
1S/C11H9N3S2/c1-2-8-13-7-3-5-15-10(7)9(14-8)11-12-4-6-16-11/h3-6H,2H2,1H3
|
||||
| InChIKey |
YNBYJWXOQPYWEM-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [529419] | |
| Adenosine A1 receptor | Target Info | Inhibitor | [529419] | ||
| Adenosine A2b receptor | Target Info | Inhibitor | [529419] | ||
| Adenosine A2a receptor | Target Info | Inhibitor | [529419] | ||
| KEGG Pathway | cGMP-PKG signaling pathway | ||||
| cAMP signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Morphine addictionhsa04015:Rap1 signaling pathway | |||||
| Calcium signaling pathway | |||||
| Vascular smooth muscle contraction | |||||
| Alcoholismhsa04015:Rap1 signaling pathway | |||||
| Parkinson's disease | |||||
| Alcoholism | |||||
| Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.